Literature DB >> 23814199

Management of refractory irritable bowel syndrome and comorbid mental ill-health: challenges, reflections and patient's perspective of life on the body-mind divide.

Itoro Udo1, Amanda Gash.   

Abstract

This complex case illustrates how blurred the divide between body and mind can be. In a patient with refractory irritable bowel symptoms, the emergence of new social problems exacerbate both psychiatric (anxiety and depression) and physical symptoms. Treatment of the physical symptomatology consisted of acute hospital treatments initially and subsequent primary care consultations. Psychiatric treatment consists of psychopharmacological (venlafaxine and mirtazapine) and psychotherapeutic approaches (cognitive behavioural therapy initially, and clinical hypnosis). The objectives of psychiatric treatment were to stabilise symptoms, reduce hospital admissions and foster self-management. The gains of management are presented. Social difficulties encountered over the period of treatment were legal processes to gain custody of son, bereavement, financial difficulties occasioned by stoppage of welfare benefits and legal processes involved in welfare appeal. Importantly, the patient's perceptive of treatment and care is presented. Detrimental effects that current welfare reforms in the UK may have on health are highlighted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23814199      PMCID: PMC3702863          DOI: 10.1136/bcr-2013-009545

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Patients' perceptions of medical explanations for somatisation disorders: qualitative analysis.

Authors:  P Salmon; S Peters; I Stanley
Journal:  BMJ       Date:  1999-02-06

2.  The hypnotic induction profile (HIP): a review of its development.

Authors:  H Spiegel
Journal:  Ann N Y Acad Sci       Date:  1977-10-07       Impact factor: 5.691

3.  The patient's perspective of irritable bowel syndrome.

Authors:  S Bertram; M Kurland; E Lydick; G R Locke; B P Yawn
Journal:  J Fam Pract       Date:  2001-06       Impact factor: 0.493

4.  Impairment in pure and comorbid generalized anxiety disorder and major depression at 12 months in two national surveys.

Authors:  R C Kessler; R L DuPont; P Berglund; H U Wittchen
Journal:  Am J Psychiatry       Date:  1999-12       Impact factor: 18.112

5.  Being in the patient position: experiences of health care among people with irritable bowel syndrome.

Authors:  Cecilia Håkanson; Eva Sahlberg-Blom; Britt-Marie Ternestedt
Journal:  Qual Health Res       Date:  2010-05-12

6.  Life events, psychiatric illness and the irritable bowel syndrome.

Authors:  M J Ford; P M Miller; J Eastwood; M A Eastwood
Journal:  Gut       Date:  1987-02       Impact factor: 23.059

Review 7.  Psychotropic agents in functional gastrointestinal disorders.

Authors:  Madhusudan Grover; Douglas A Drossman
Journal:  Curr Opin Pharmacol       Date:  2008-09-09       Impact factor: 5.547

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Biopsychosocial model of irritable bowel syndrome.

Authors:  Yukari Tanaka; Motoyori Kanazawa; Shin Fukudo; Douglas A Drossman
Journal:  J Neurogastroenterol Motil       Date:  2011-04-27       Impact factor: 4.924

Review 10.  Guidelines on the irritable bowel syndrome: mechanisms and practical management.

Authors:  R Spiller; Q Aziz; F Creed; A Emmanuel; L Houghton; P Hungin; R Jones; D Kumar; G Rubin; N Trudgill; P Whorwell
Journal:  Gut       Date:  2007-05-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.